ArticleBMJ global health2019
Strengthening strategic management approaches to address antimicrobial resistance in global human health: a scoping review.
Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Practices and Perspectives of Lead Implementers on Implementation of Antimicrobial Resistance Strategic Plan: A Cross-Sectional Descriptive Study in Ethiopia.Tropical medicine & international health : TM & IH · 2026Article
- Mind the governance gap: a one health scoping review of national AMR performance indicators.npj antimicrobials and resistance · 2026Article
- Community engagement strategies for antimicrobial resistance control and interventions.BMJ public health · 2026Review
- Responding to and managing antibiotic shortages: a qualitative study with experts and opinion leaders.Wellcome open research · 2025Article
- Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions.Nature reviews. Microbiology · 2024Review
- Systems Policy Analysis for Antimicrobial Resistance Targeted Action (SPAARTA): A Research Protocol.Wellcome open research · 2024Article
- Article
- Evaluating Antibiotic Treatment Guideline Adherence to Ongoing Antibiotic Stewardship in a Tertiary Care Setting: A Retrospective Observational Study.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024Article
- Mitigating antimicrobial resistance (AMR) using implementation research: a development funder's approach.JAC-antimicrobial resistance · 2023Review
- Interventional research to tackle antimicrobial resistance in Low Middle Income Countries in the era of the COVID-19 pandemic: lessons in resilience from an international consortium.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Antimicrobial stewardship in Latin America: Past, present, and future.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022Review
- Socioeconomic Factors Contributing to Antibiotic Resistance in China: A Panel Data Analysis.Antibiotics (Basel, Switzerland) · 2021Article
- Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for research.The Lancet regional health. Europe · 2021Review
- Macro level influences on strategic responses to the COVID-19 pandemic - an international survey and tool for national assessments.Journal of global health · 2021Review
- Macro level factors influencing strategic responses to emergent pandemics: A scoping review.Journal of global health · 2021Article
- What are the challenges for antibiotic stewardship at the community level? An analysis of the drivers of antibiotic provision by informal healthcare providers in rural India.Social science & medicine (1982) · 2021Article
- Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020Review
- Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy.BMJ global health · 2020Review
- Paving the Way for the Implementation of a Decision Support System for Antibiotic Prescribing in Primary Care in West Africa: Preimplementation and Co-Design Workshop With Physicians.Journal of medical Internet research · 2020Article
- Tackling antimicrobial resistance in low-income and middle-income countries.BMJ global health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe development and implementation of national strategic plans is a critical component towards successfully addressing antimicrobial resistance (AMR). This study aimed to review the scope and analytical depth of situation analyses conducted to address AMR in human health to inform the development and implementation of national strategic plans.
methodsA systematic search of the literature was conducted to identify all studies since 2000, that have employed a situation analysis to address AMR. The included studies are analysed against frameworks for strategic analysis, primarily the PESTELI (Political, Economic, Sociological, Technological, Ecological, Legislative, Industry) framework, to understand the depth, scope and utility of current published approaches.
results10 studies were included in the final review ranging from single country (6) to regional-level multicountry studies (4). 8 studies carried out documentary review, and 3 of these also included stakeholder interviews. 2 studies were based on expert opinion with no data collection. No study employed the PESTELI framework. Most studies (9) included analysis of the political domain and 1 study included 6 domains of the framework. Technological and industry analyses is a notable gap. Facilitators and inhibitors within the political and legislative domains were the most frequently reported. No facilitators were reported in the economic or industry domains but featured inhibiting factors including: lack of ring-fenced funding for surveillance, perverse financial incentives, cost-shifting to patients; joint-stock drug company ownership complicating regulations.
conclusionThe PESTELI framework provides further opportunities to combat AMR using a systematic, strategic management approach, rather than a retrospective view. Future analysis of existing quantitative data with interviews of key strategic and operational stakeholders is needed to provide critical insights about where implementation efforts should be focussed, and also how to build contingency at the strategic level for agile responses to macro-level environmental influences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.